Author(s):
Kharat Sunanda Bhavrao, Hrushikesh D. Jorwar, Sonali S. Borde
Email(s):
sunandakharat2001@gmail.com
DOI:
10.52711/2321-5836.2025.00019 
Address:
Kharat Sunanda Bhavrao*, Hrushikesh D. Jorwar, Sonali S. Borde
KVN Naik SPS Institute of Pharmaceutical Education and Research, DBATU University, Canada Corner, Nashik – 422002, Maharashtra, India.
SND College of Engineering Research Centre Yeola, Nashik 422002, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 2,
Year - 2025
ABSTRACT:
The clinical review of Moyamoya disease (MMD) and Moyamoya syndrome is presented in this article (MMS). We discuss the prevalence, epidemiology, pathology, historical background, clinical and radiographic findings, diagnostic imaging modalities, radiographic grading systems, the efficacy of medical, interventional, and surgical treatment, as well as some of the subtleties of surgical treatment options. Pediatricians, neurologists, neurosurgeons, and other clinical professionals who are involved in treating patients with this uncommon clinical entity will benefit from reading this article. MMD may be a inveterate occlusive cerebrovascular malady characterized by dynamic stenosis of the terminal portion of the inside carotid supply route and an anomalous vascular arrange at the base of the brain. It is an intrinsic primary disease process that results in bilateral progressive stenosis of the anterior intracranial circulation, with involvement of the proximal portions of the intracranial internal carotid artery (ICA), extending to involve the proximal portions of the anterior cerebral artery (ACA), and middle cerebral artery (MCA). Moyamoya disease has several unique clinical features, which include two peaks of age distribution at 5 year and at about 40 year. A growing number of patients are benefiting from intracranial and extracranial revascularization, which is a common surgical treatment for MMD.Based on previous research; In this review, we summarise the epidemiology, etiology, clinical features, diagnosis, surgical treatement and outcomes of moyamoya disease. Recent updates and future perspectives of moyamoya disease are also discussed. Recent updates and future perspectives of moyamoya disease are also discussed.
Cite this article:
Kharat Sunanda Bhavrao, Hrushikesh D. Jorwar, Sonali S. Borde. A Review on Moyamoya Disease – (Rare Brain Disease). Research Journal of Pharmacology and Pharmacodynamics.2025;17(2):115-0. doi: 10.52711/2321-5836.2025.00019
Cite(Electronic):
Kharat Sunanda Bhavrao, Hrushikesh D. Jorwar, Sonali S. Borde. A Review on Moyamoya Disease – (Rare Brain Disease). Research Journal of Pharmacology and Pharmacodynamics.2025;17(2):115-0. doi: 10.52711/2321-5836.2025.00019 Available on: https://rjppd.org/AbstractView.aspx?PID=2025-17-2-6
REFERENCE:
1. Gupta A, Tyagi A, Romo M, et al. Moyamoya Disease: A Review of Current Literature. Cureus. 2020; 12(8): e10141.DOI 10.7759/cureus.10141
2. Demartini Z Jr, Teixeira BCA. Koppe GL, Gatto LAM, Roman A, Munhoz RP. Moyamoya disease and syndrome: a review. Radiol Bras. 2022; 55 (1):31-37.
3. KB, Akhtar N, Syed NA, Shafqat S, Baig SM: Moyamoya disease: an elusive diagnosis. JPMA. 2003, 53 (4):160-162.
4. Jong S. Kim, et al. Moyamoya Disease: Epidemiology, Clinical Features and Diagnosis. 2015
5. Yongjun Wang and Jizong Zhao; A review on Epidemiology of Moyamoya disease in china: A nationwide hospital – based study; published by Elsevier Ltd. (http://creativecommons.org/licenses/by.nc.nd/4.0/).
6. Drs. Hann and Ahn; review on Incidence, Prevalence, and Survival of Moyamoya Disease in Korea; http://stroke.ahajournals.org/lookup/suppl/doi:10.1161/STROKEAHA.113.004273/-/DCI.
7. Das S, Dubey S, Das S, Hazra a, pandit A, Ghosh R and Ray Bk (2022) Epidemiology of Moyamoya Angiopathy in Eastern India. Front. Neurol. 13: 837704.doi:10.3389/Fneur.2022.837704.
8. Menon G, Hegde A. Moyamoya disease. Arch Med Health Sci. 2019; 7: 224-32.
9. Kleinloog R, Regli L, Rinkel GJE, et al. Regional difference in incidence and patient charachetristics of moyamoya disease: a systematic review. Journal of Neurology, neurosurgery & Psychiatry 2012; 83: 531-536. (http://dx.doi.org/10.1136/jnnp-2011-301387)
10. Guliz Acker, Lucius Fekonja, Peter Vajkoczy; Surgical Management of moyamoya disease. Stroke. 2018; 49(2): 476-482. (http://doi.org/10.1161/STROKEAHA.117.018563)
11. Paritosh Pandey, Gary K Steinberg; Neurosurgical advances in the treatment of moyamoya disease. Stroke. 2011; 42(11): 3304-3310.
12. Kiyohiro Houkin, Masaki Ito, Sugiyama, Hideo Shichinohe, Naoki Nakayama, Ken Kazumata, Satoshi Kuroda. Review of past research and current concepts on the etiology of moyamoya disease. Neurologia Medica-Chirurgica. 2012; 52(5): 267-277.
13. Keisuke Ueki, Fredric B Meyer, James F Mellinger; Mayo Clinic Proceedings. 1994; 69(8): 749-757.
14. Miki Fujimura, Teiji Tominaga. Diagnosis of moyamoya disease: international standard and regional differences. Neurologia Medico-Chirurgica. 2015; 55(3): 189-193.
15. Stephanie Guey, Elisabeth Tournier-Lasserve, Dominique Herve, Manoelle Kossorotoff. Moyamoya disease and syndromes: from genetics to clinical management; the application of clinical genetics. 2015: 49-68.
16. Takeshi Mikami, Hime Suzuki, Katsuya Komatsu, Nobuhiro Mikuni. Influence of inflammatory disease on the pathophysiology of moyamoya disease and quasi-moyamoya disease. Neurologia medico-Chirurgica. 2019; 59(10): 361.
17. Eric J Arias, Colin P Derdeyn, Ralph G Dacey Jr, Gregory J Zipfel. Advances and surgical considerations in the treatment of moyamoya disease. Neurosurgery. 2014; 74(suppl_1): S116-S125,
18. Annick Kronenburg, Kees PJ Braun, Albert van der Zwan, Catharina JM Klijn. Recent advances in moyamoya disease: pathophysiology and treatment. Current Neurology and Neuroscience Reports. 2014; 14: 1-9.
19. Gosalakkal J A. Moyamoya Disease: A Review. Neurol India 2002; 50: 6-10. (hhtp://www.neurologyindia.com/text.asp?2002/50/1/6/1371).
20. KVNR, A. and KV, R. 2017. Moya Moya Disease- A review. Asian Journal of Pharmaceutical and Clinical Research. 2017; 10 (4): 14-20.DOI: hhtp://doi.org/10.22159/ajpcr.2017.v10i4.13453.
21. Ohkubo, K., Y., Inoue, H. et al. Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cekks. Sci Rep. 2015; 5: 13191. http://doi.org/10.1038/srep13191.
22. Deng X, Zhang D, Zhang Y, Wang R, Wang B, Zhao J. J Clin Neurosci. 2017; 42.
23. Moyamoya disease with occlusion of bilateral vertebral arteries and the basilar artery fed by the collateral vessels of vertebral arteries. A Rare Case Report. 116–118.
24. Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of moyamoya disease; Exp Ther Med. 2019; 17: 1977–1984.
25. Hishikawa T, Sugiu K, Date I. Moyamoya disease: a review of clinical research; Acta Med Okayama. 2016; 70: 229–236.
26. Surgical management of moyamoya disease. Acker G, Fekonja L, Vajkoczy P. Stroke. 2018; 49: 476–482.
27. Suzuki J and Takaku A. Cerebrovascular ‘moyamoya’ disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969; 20: 288–299.
28. Baba T, Houkin K and Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008; 79: 900–904.
29. Hayashi T, Shirane R and Tominaga T. Additional surgery for postoperative ischemic symptoms in patients with moyamoya disease: The effectiveness of occipital artery-posterior cerebral artery bypass with an indirect procedure. Technical Case Report. Neurosurgery. 2009; 64: E195–E196.
30. Kim JS, Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis. Journal of Stroke. 2016
31. Wang G, Zhang X, Feng M, Liu X, Guo F, Efficacy of Surgical Treatment on the Recurrent Stroke Prevention for Adult Patients with Hemorrhagic Moyamoya Disease. The Journal of Craniofacial Surgery. 2017